This study is designed as a prospective observational study. The patient files will be used to

gather demographic information about the patients, such as age, gender. Vital indicators like

oxygen saturation (SpO2) and heart rate (HR) will be monitored during the procedure.

Following IVC, patients in both groups will use the Visual Analog Scale (VAS) and the Verbal

Descriptor Scale (VDS) to rate their level of discomfort. Two subgroups will be created from

the patients using EMLA CREAM and Lidocaine HCL during IVC- a routine procedure done

on the dorsum of the hand (Cephalic vein, basilic vein, dorsal metacarpal vein), will be carried

out by same anaesthesiologist, in the ward and pre-operative settings, each containing 57

participants.

In Group E (EMLA CREAM) the site where IVC is planned will be covered in padded dressing

impregnated with a thick layer of 1 mL (or 1 gram) of EMLA cream and left for 30 minutes.

After 30minutes the padded dressing will be removed and an effort will be made to perform

intravenous cannulation using a suitable gauged cannula by an experienced assigned

anaesthesiologist. In group L (Lidocaine HCL) a padded dressing impregnated with a 10%

lidocaine HCL pump spray solution will be applied to the skin where IVC is planned and left

in place for 30 minutes and cannulation is carried out by an anaesthesiologist while the

principal investigator will be observing and documenting the pain scores. The Visual Analogue

Scale (VAS) scores and VDS scores will be recorded, and hemodynamic parameters will be

monitored during the procedure. Assessing effectiveness typically involves standardized pain

measurement tools like the Verbal Descriptor Scale (VDS) and the Visual Analogue Scale

(VAS). The VDS allows patients to describe pain using terms such as "no pain" or "severe,"

while the VAS uses a 10-centimeter line to quantify pain intensity.